Yield10 Bioscience, Inc. (YTEN) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts YTEN Hot Sheet
Join SI Premium – FREE
Yield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q2 EPS of ($0.64), $0.03 worse than the analyst estimate of ($0.61).
For earnings history and earnings-related data on Yield10 Bioscience, Inc. (YTEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi raises Keurig Dr Pepper price target to $40
- Hecla Mining (HL) Tops Q3 EPS by 7c
- Triple Flag Precious Metals Corp. (TFPM) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
